This is an unofficial version. If you need an official copy, use the PDF version.
As of January 20, 2025, this is the most current version available.
It has been in effect since September 1, 2024.
Last amendment included: M.R. 48/2024
Previous version(s)
- 1 Sept. 2023 to 31 Aug. 2024 — HTML version (first version)
Note: Earlier consolidated versions are not available online.
Amendments
Amendment | Title | Registered | Published |
48/2024 | Occupational Diseases Regulation, amendment | 26 June 2024 | 26 June 2024 |
Occupational Diseases Regulation, M.R. 69/2023
« Occupational Diseases Regulation », R.M. 69/2023
The Workers Compensation Act, C.C.S.M. c. W200
NOTE: This regulation was enacted in English only.
Loi sur les accidents du travail, c. W200 de la C.P.L.M.
NOTE : Ce règlement a été adopté en anglais seulement.
version anglaiseRegulation 69/2023
Registered June 21, 2023
Schedule of occupational diseases established
1 The Schedule to this regulation is adopted as the schedule of occupational diseases for the purpose of subsection 4(4.1) of The Workers Compensation Act.
Coming into force
2 This regulation comes into force on September 1, 2023, or the day it is registered under The Statutes and Regulations Act, whichever is later.
June 21, 2023The Workers Compensation Board:
Michael D. Werier, Chair
SCHEDULE
Item | Column 1 Occupational Disease |
Column 2 Industry, Trade or Process |
1. | Poisoning by: | |
(a) Arsenic |
Where there is occupational exposure to arsenic or arsenic compounds. | |
(b) Asphyxiants |
Where there is occupational exposure to carbon monoxide, hydrogen sulfide or hydrogen cyanide. | |
(c) Benzene |
Where there is occupational exposure to benzene or its homologues. | |
(d) Beryllium |
Where there is occupational exposure to beryllium or beryllium compounds. | |
(e) Cadmium |
Where there is occupational exposure to cadmium or cadmium compounds. | |
(f) Fluorine |
Where there is occupational exposure to fluorine or fluorine compounds. | |
(g) Lead |
Where there is occupational exposure to lead or lead compounds. | |
(h) Manganese |
Where there is occupational exposure to manganese or manganese compounds. | |
(i) Oxides of nitrogen |
Where there is occupational exposure to nitrous fumes or the oxides of nitrogen. | |
(j) Phosgene |
Where there is occupational exposure to phosgene. | |
(k) Phosphorus |
Where there is occupational exposure to phosphorus or phosphorus compounds. | |
(l) Ammonia |
Where there is occupational exposure to ammonia or ammonia compounds. | |
(m) Chlorine |
Where there is occupational exposure to chlorine or chlorine compounds. | |
(n) Mercury |
Where there is occupational exposure to mercury or mercury compounds. | |
2. | Diseases caused by ionizing radiation | Where there is occupational exposure to ionizing radiation. |
3. | Asbestosis | Where there is occupational exposure to airborne asbestos dust. |
4. | Silicosis | Where there is occupational exposure to airborne silica dust. |
5. | Other pneumoconioses | Where there is occupational exposure to the airborne dusts of coal, beryllium, tungsten carbide, aluminum or other dusts known to produce fibrosis of the lungs. |
6. | Extrinsic allergic alveolitis | Where there is occupational exposure to respirable organic dusts. |
7. | Contact dermatitis | Where there is occupational contact with allergens or sensitizers that ordinarily cause dermatitis. |
8. | Skin cancer | Where there is occupational contact with coal tar products, such as tar, pitch, bitumen, mineral oil or paraffin or any compound or residue of these products. |
9. | Primary cancer of the mucous lining of the nose or nasal sinuses | Where there is occupational exposure to:
(a) dusts, fumes or mists containing nickel; or (b) the dusts of hard woods. |
10. | Mesothelioma, whether pleural or peritoneal | Where there is occupational exposure to airborne asbestos dust. |
10.1. | Primary carcinoma of the lung when associated with asbestosis | Where there is occupational exposure to airborne asbestos dust. |
10.2. | Primary carcinoma of the lung | Where there is exposure to airborne asbestos dust for a period of employment of 10 years or more in one or more of the following industries:
(a) asbestos mining; (b) insulation or filter material production; (c) construction, where there is disturbance of asbestos-containing materials; (d) plumbing or electrical work; (e) pulp mill work; (f) shipyard work; (g) longshoring. |
10.3. | Carcinoma of the larynx or pharynx when associated with asbestosis | Where there is occupational exposure to airborne asbestos dust. |
11. | Infection caused by: | |
(a) Salmonella organisms, Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA), or Hepatitis B |
Where there is occupational contact with a source or sources of the infection, and the worker's employment involves
(a) treating, nursing, examining or interviewing patients or ill persons; (b) analyzing or testing body tissues or fluid; or (c) research into salmonellae, pathogenic staphylococci or hepatitis B virus in a laboratory setting. |
|
(b) Brucella organisms |
Where there is occupational contact with
(a) animals, animal carcasses or animal by-products; or (b) Brucella organisms in a laboratory setting. |
|
(c) Tubercle bacillus |
Where there is occupational contact with a source or sources of the infection, and the worker's employment involves
(a) treating, nursing, examining or interviewing patients or ill persons; (b) analyzing or testing body tissues or fluids; or (c) research into tuberculosis in a laboratory setting. |